Recent studies have shown that matrine can diminish inflammatory responses and oxidative stress by blocking the IL-6/STAT3 signaling pathway, thereby attenuating intestinal mucosal damage in rats with inflammatory bowel disease (IBD) [106]. The gene discussed is IL6; the disease is inflammatory bowel disease.